Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Diaceutics Posts 75% ARR Growth as Precision-Medicine Data Group Builds a Recurring-Revenue Engine

The LSE-listed diagnostics data firm behind the DXRX platform reported annual recurring revenue up 75% in its latest trading update, alongside falling churn and a swelling order book. Here is what the numbers actually show.

Ankur Sharma | 10 August 2026

Could Imaging Biometrics LSE:IBAI’s 11.11% Surge Signal Growing Investor Confidence in Its Brain Cancer Technology?

Imaging Biometrics Limited LSE:IBAI was among the notable healthcare movers on 7 August 2026, rising11.11%as investor attention returned to the company's developing clinical and commercial story.

Ankur Sharma | 10 August 2026

Could ProBiotix Health’s Cardiometabolic Probiotics Become a Major International Growth Story?

ProBiotix Health PLC has moved sharply higher, withLSE:PBX gaining 20.81% on 7 August 2026.

Ankur Sharma | 10 August 2026

Could Renalytix’s KidneyIntelX Platform Become a Major AI-Driven Precision Medicine Opportunity?

Renalytix plc has returned to investor focus afterLSE:RENX gained 13.85% on 7 August 2026.

Ankur Sharma | 10 August 2026

Could BSF Enterprise’s Lab-Grown Leather, Regenerative Medicine and Biotechnology Assets Unlock Major Growth?

BSF Enterprise PLC has attracted renewed investor attention afterLSE:BSFA gained 22.22% on 7 August 2026.

Ankur Sharma | 10 August 2026

Could DXS International’s Healthcare Technology Platform Become a Major NHS Growth Story?

DXS International PLC has moved sharply higher, withLSE:DXSP gaining 25.00% on 7 August 2026.

Ankur Sharma | 10 August 2026

Could Genflow’s SIRT6 Gene-Therapy Platform Become a Major Longevity Biotechnology Opportunity?

Genflow Biosciences PLC has attracted renewed attention afterLSE:GENF gained 13.89% on 7 August 2026.

Ankur Sharma | 10 August 2026

Oxford Nanopore Technologies Back in Focus as Precision Medicine and Genomics Expand

Oxford Nanopore Technologies Plc (LSE:ONT) recorded a positive trading session on7 August 2026, with its shares advancing3.49%as investors increased exposure to healthcare technology companies positioned to benefit from continued advances in genomics and precision medicine.

Ankur Sharma | 07 August 2026

CT Healthcare Trust Share Price Drops: What Investors Should Watch Next

CT Healthcare Trust Plc experienced a2.89%decline during trading on7 August 2026, reflecting weaker investor sentiment toward healthcare-focused investment trusts.

Ankur Sharma | 07 August 2026

Fevara Share Price Drops: What Could Drive the Next Move?

Fevara PLC ended the trading session2.78%lower on7 August 2026, placing the stock among the weaker performers during the day.

Ankur Sharma | 07 August 2026
Support

Hi! How can we help you today?

Loading…